GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Cyclically Adjusted Revenue per Share

Medicure (TSXV:MPH) Cyclically Adjusted Revenue per Share : C$1.78 (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Medicure Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medicure's adjusted revenue per share for the three months ended in Dec. 2023 was C$0.485. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is C$1.78 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Medicure's average Cyclically Adjusted Revenue Growth Rate was 13.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 17.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 14.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 16.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medicure was 22.10% per year. The lowest was 12.20% per year. And the median was 15.50% per year.

As of today (2024-04-30), Medicure's current stock price is C$1.07. Medicure's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was C$1.78. Medicure's Cyclically Adjusted PS Ratio of today is 0.60.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medicure was 15.43. The lowest was 0.31. And the median was 4.08.


Medicure Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Medicure's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure Cyclically Adjusted Revenue per Share Chart

Medicure Annual Data
Trend May14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.02 1.09 1.30 1.57 1.78

Medicure Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.52 1.57 1.64 1.73 1.78

Competitive Comparison of Medicure's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Medicure's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicure's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicure's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medicure's Cyclically Adjusted PS Ratio falls into.



Medicure Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medicure's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.485/125.4675*125.4675
=0.485

Current CPI (Dec. 2023) = 125.4675.

Medicure Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201308 0.061 97.261 0.079
201311 0.071 97.182 0.092
201402 0.129 98.051 0.165
201405 0.147 99.394 0.186
201408 0.153 99.315 0.193
201503 0.234 99.789 0.294
201506 0.260 100.500 0.325
201509 0.377 100.421 0.471
201512 0.581 99.947 0.729
201603 0.364 101.054 0.452
201606 0.456 102.002 0.561
201609 0.494 101.765 0.609
201612 0.358 101.449 0.443
201703 0.394 102.634 0.482
201706 0.453 103.029 0.552
201709 0.395 103.345 0.480
201712 0.261 103.345 0.317
201803 0.342 105.004 0.409
201806 0.440 105.557 0.523
201809 0.467 105.636 0.555
201812 0.503 105.399 0.599
201903 0.315 106.979 0.369
201906 0.411 107.690 0.479
201909 0.371 107.611 0.433
201912 0.243 107.769 0.283
202003 0.279 107.927 0.324
202006 0.245 108.401 0.284
202009 0.333 108.164 0.386
202012 0.270 108.559 0.312
202103 0.482 110.298 0.548
202106 0.496 111.720 0.557
202109 0.480 112.905 0.533
202112 0.664 113.774 0.732
202203 0.593 117.646 0.632
202206 0.561 120.806 0.583
202209 0.523 120.648 0.544
202212 0.555 120.964 0.576
202303 0.582 122.702 0.595
202309 0.595 125.230 0.596
202312 0.485 125.468 0.485

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Medicure  (TSXV:MPH) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medicure's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.07/1.78
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medicure was 15.43. The lowest was 0.31. And the median was 4.08.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medicure Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Medicure's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicure (TSXV:MPH) Business Description

Industry
Traded in Other Exchanges
Address
2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6
Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.

Medicure (TSXV:MPH) Headlines

No Headlines